POEMS Syndrome: A Case Report and Review of the Literature
- PMID: 35989837
- PMCID: PMC9386312
- DOI: 10.7759/cureus.27001
POEMS Syndrome: A Case Report and Review of the Literature
Abstract
Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein elevation, and skin changes (POEMS) syndrome is a rare multisystem disorder that occurs due to an underlying plasma cell dyscrasia. A diagnosis is made with the presence of two mandatory criteria and at least one major and one minor criterion. We present a case of a 28-year-old patient who presented with weakness of bilateral arms and legs, thinning of hands, and swelling of bilateral lower limbs and abdomen. The patient also reported weight loss and loss of appetite. Examination revealed areflexic quadriparesis with sensory loss, diffuse lymphadenopathy, pleural effusion, ascites, and pulmonary hypertension. Investigations showed elevated erythrocyte sedimentation rate (ESR). Nerve conduction studies revealed severe axonal polyneuropathy of all nerves. Lymph node biopsy showed Castleman disease. A diagnosis of POEMS syndrome was made and he was sent for a stem cell transplant, which is the definitive treatment in patients eligible for stem cell transplant.
Keywords: castleman disease; castleman variant of poems syndrome; plasma cell dyscrasia; poems syndrome; systemic autoimmune disease.
Copyright © 2022, Kanuganti et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
Diagnostic Challenges of Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, and Skin Changes (POEMS) Syndrome: A Rare Case Report and Review of the Literature.Cardiovasc Hematol Disord Drug Targets. 2025 Mar 13. doi: 10.2174/011871529X352283250305042317. Online ahead of print. Cardiovasc Hematol Disord Drug Targets. 2025. PMID: 40143390
-
POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Plasma Cell Disorder, and Skin Changes) Syndrome as a Sequela of Castleman Disease: A Case Report.Cureus. 2023 Nov 24;15(11):e49330. doi: 10.7759/cureus.49330. eCollection 2023 Nov. Cureus. 2023. PMID: 38143657 Free PMC article.
-
Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report.J Med Case Rep. 2019 Dec 27;13(1):384. doi: 10.1186/s13256-019-2309-z. J Med Case Rep. 2019. PMID: 31878962 Free PMC article.
-
Pituitary macroadenoma in a patient with POEMS syndrome in conjunction with Castleman disease: first report of a case and review of related literature.Endocr Pract. 2010 Jan-Feb;16(1):97-101. doi: 10.4158/EP09027.CRR. Endocr Pract. 2010. PMID: 19546057 Review.
-
POEMS syndrome: A multisystem clonal disorder.Eur J Haematol. 2021 Jan;106(1):14-18. doi: 10.1111/ejh.13514. Epub 2020 Oct 8. Eur J Haematol. 2021. PMID: 32889731 Review.
Cited by
-
Pulmonary manifestations of POEM syndrome: a retrospective analysis of 282 cases.BMC Pulm Med. 2023 Nov 23;23(1):465. doi: 10.1186/s12890-023-02741-9. BMC Pulm Med. 2023. PMID: 37993859 Free PMC article.
References
-
- POEMS syndrome: definitions and long-term outcome. Dispenzieri A, Kyle RA, Lacy MQ, et al. Blood. 2003;101:2496–2506. - PubMed
-
- Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Medicine (Baltimore) 1980;59:311–322. - PubMed
-
- Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Li J, Zhou DB, Huang Z, et al. Ann Hematol. 2011;90:819–826. - PubMed
-
- POEMS syndrome. Keddie S, Lunn MP. Curr Opin Neurol. 2018;31:551–558. - PubMed
-
- POEMS syndrome: 2019 update on diagnosis, risk-stratification, and management. Dispenzieri A. Am J Hematol. 2019;94:812–827. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous